Androgen administration has been shown to exert an anti-proliferative effect in ERα- breast cancer cell lines through the AR-mediated up-regulation of the tumour suppressors PTEN, which, in turn, by inducing p53 and p73 expression, promotes apoptosis [30,31]. Here, ESR1 is linked to breast carcinoma.